About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Pharmacy
›
top-articles
Department of Pharmacy
26
(top 2%)
papers
961
(top 2%)
citations
11
(top 2%)
h
-index
21
(top 2%)
g
-index
27
all documents
1.0K
doc citations
462
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
Molecular Therapy
2009
346
2
Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution
Kidney International
2002
242
3
Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage
Infection Control and Hospital Epidemiology
2012
67
4
Pneumocystis
pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (
HIV
)‐infected and
HIV
‐uninfected persons
Transplant Infectious Disease
2012
65
5
Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines
Diagnostic Microbiology and Infectious Disease
2005
50
6
The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable?
Current Transplantation Reports
2015
46
7
Observational study of the epidemiology and outcomes of vancomycin-resistant
Enterococcus
bacteraemia treated with newer antimicrobial agents
Epidemiology and Infection
2011
41
8
Metabolic Complications of Total Parenteral Nutrition: Effects of a Nutrition Support Service
Journal of Parenteral and Enteral Nutrition
1996
37
9
Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center
Gastroenterology Research
2018
31
10
Survey of the Stocking of Poison Antidotes in Alabama Hospitals
Southern Medical Journal
1999
17
11
A Continuous Veno-Venous Hemofiltration Protocol with Anticoagulant Citrate Dextrose Formula a and a Calcium-Containing Replacement Fluid
International Journal of Artificial Organs
2014
14
12
Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients
Gynecologic Oncology
2021
11
13
The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?
Gynecologic Oncology
2021
10
14
Is memantine a potential therapeutic for Rett syndrome?
Frontiers in Neuroscience
2013
6
15
Collaborative cardiovascular management of patients with chronic myeloid leukemia on tyrosine kinase inhibitors
Vascular Medicine
2020
6
16
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents
Leukemia and Lymphoma
2022
5
17
Detection of rarely identified multiple mutations in
MECP2
gene do not contribute to enhanced severity in rett syndrome
American Journal of Medical Genetics, Part A
2013
4
18
Letter to the Editor: “Use of inhaled epoprostenol with high flow nasal oxygen in non-intubated patients with severe COVID-19”
Journal of Critical Care
2022
4
19
Increasing Prevalence of Pediatric Community-acquired UTI by Extended Spectrum β-Lactamase-producing E. coli: Cause for Concern
Pediatric Infectious Disease Journal
2023
2
20
Outsourcing: A success story
American Journal of Health-System Pharmacy
1997
1
21
Myocardial ischemia with fluorouracil and floxuridine therapy
Clinical Pharmacy
1987
1
22
Superiority of fixed-dose warfarin for chronic anticoagulation
Journal of Stroke and Cerebrovascular Diseases
2004
0
23
Improvement of Gram-negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long Experience
Open Forum Infectious Diseases
2017
0
24
AML-430: Utility of End-of-Induction Bone Marrow Biopsy in APL Patients Treated with ATRA/ATO Regimen
Clinical Lymphoma, Myeloma and Leukemia
2021
0
25
Poster: AML-430: Utility of End-of-Induction Bone Marrow Biopsy in APL Patients Treated with ATRA/ATO Regimen
Clinical Lymphoma, Myeloma and Leukemia
2021
0
26
Survival outcomes of patients with relapsed or refractory acute myeloid leukemia after venetoclax combined with hypomethylating agents.
Journal of Clinical Oncology
2022
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.